Latest news
Intellia Prepares for Anticipated 2027 Commercial Launch of First In Vivo Gene Editor - Precision Medicine OnlinePrecision Medicine Online · Thu, 06 Aug 2026 19:23:40 GMTSarepta Narrows 2026 Revenue Guidance on Elevidys Q2 Sales Dip - Precision Medicine OnlinePrecision Medicine Online · Thu, 06 Aug 2026 13:13:27 GMTEli Lilly Cuts Gaucher Disease Gene Therapy From Pipeline - Precision Medicine OnlinePrecision Medicine Online · Wed, 05 Aug 2026 19:39:33 GMTCRISPR Therapeutics Launches Clinical Trials of In Vivo Gene Editors for Hypertension, AATD - Precision Medicine OnlinePrecision Medicine Online · Tue, 04 Aug 2026 14:29:21 GMTVertex Raises 2026 Revenue Forecast on Strong Growth in Cystic Fibrosis Drug Sales - Precision Medicine OnlinePrecision Medicine Online · Tue, 04 Aug 2026 14:06:26 GMTGermany's Precision Medicine Pilot Project Gains Steam After Putting Data Infrastructure in Place - GenomeWebGenomeWeb · Mon, 27 Jul 2026 19:23:44 GMT